Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.

Pauthner MG, Nkolola JP, Havenar-Daughton C, Murrell B, Reiss SM, Bastidas R, Prévost J, Nedellec R, von Bredow B, Abbink P, Cottrell CA, Kulp DW, Tokatlian T, Nogal B, Bianchi M, Li H, Lee JH, Butera ST, Evans DT, Hangartner L, Finzi A, Wilson IA, Wyatt RT, Irvine DJ, Schief WR, Ward AB, Sanders RW, Crotty S, Shaw GM, Barouch DH, Burton DR.

Immunity. 2019 Jan 15;50(1):241-252.e6. doi: 10.1016/j.immuni.2018.11.011. Epub 2018 Dec 11.


Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization.

Bianchi M, Turner HL, Nogal B, Cottrell CA, Oyen D, Pauthner M, Bastidas R, Nedellec R, McCoy LE, Wilson IA, Burton DR, Ward AB, Hangartner L.

Immunity. 2018 Aug 21;49(2):288-300.e8. doi: 10.1016/j.immuni.2018.07.009. Epub 2018 Aug 7.


Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.

Rogers TF, Goodwin EC, Briney B, Sok D, Beutler N, Strubel A, Nedellec R, Le K, Brown ME, Burton DR, Walker LM.

Sci Immunol. 2017 Aug 18;2(14). pii: eaan6809. doi: 10.1126/sciimmunol.aan6809.


High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.

Nedellec R, Herbeck JT, Hunt PW, Deeks SG, Mullins JI, Anton ED, Reeves JD, Mosier DE.

AIDS Res Hum Retroviruses. 2017 Mar;33(3):234-245. doi: 10.1089/AID.2016.0153. Epub 2016 Oct 12.


Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins.

Dobrowsky TM, Rabi SA, Nedellec R, Daniels BR, Mullins JI, Mosier DE, Siliciano RF, Wirtz D.

Sci Rep. 2013 Oct 22;3:3014. doi: 10.1038/srep03014.


Childhood infections, but not early life growth, influence hearing in the Newcastle thousand families birth cohort at age 14 years.

Pearson F, Mann KD, Nedellec R, Rees A, Pearce MS.

BMC Ear Nose Throat Disord. 2013 Jul 29;13:9. doi: 10.1186/1472-6815-13-9. eCollection 2013.


CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.

Choi WT, Nedellec R, Coetzer M, Colin P, Lagane B, Offord RE, Hartley O, Mosier DE.

J Virol. 2012 Sep;86(18):10218-20. doi: 10.1128/JVI.00353-12. Epub 2012 Jul 11.


Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.

Jiang C, Parrish NF, Wilen CB, Li H, Chen Y, Pavlicek JW, Berg A, Lu X, Song H, Tilton JC, Pfaff JM, Henning EA, Decker JM, Moody MA, Drinker MS, Schutte R, Freel S, Tomaras GD, Nedellec R, Mosier DE, Haynes BF, Shaw GM, Hahn BH, Doms RW, Gao F.

J Virol. 2011 Oct;85(20):10669-81. doi: 10.1128/JVI.05249-11. Epub 2011 Aug 10.


Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.

Nedellec R, Coetzer M, Lederman MM, Offord RE, Hartley O, Mosier DE.

PLoS One. 2011;6(7):e22020. doi: 10.1371/journal.pone.0022020. Epub 2011 Jul 8.


Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.

Coetzer M, Nedellec R, Cilliers T, Meyers T, Morris L, Mosier DE.

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):9-15. doi: 10.1097/QAI.0b013e3181f63906.


"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance.

Nedellec R, Coetzer M, Lederman MM, Offord RE, Hartley O, Mosier DE.

J Virol. 2010 Jun;84(11):5842-5. doi: 10.1128/JVI.01907-09. Epub 2010 Mar 24.


Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region.

da Silva J, Coetzer M, Nedellec R, Pastore C, Mosier DE.

Genetics. 2010 May;185(1):293-303. doi: 10.1534/genetics.109.112458. Epub 2010 Feb 15.


Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.

Nedellec R, Coetzer M, Shimizu N, Hoshino H, Polonis VR, Morris L, Mårtensson UE, Binley J, Overbaugh J, Mosier DE.

J Virol. 2009 Sep;83(17):8353-63. doi: 10.1128/JVI.00780-09. Epub 2009 Jun 24.


Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Gaertner H, Cerini F, Escola JM, Kuenzi G, Melotti A, Offord R, Rossitto-Borlat I, Nedellec R, Salkowitz J, Gorochov G, Mosier D, Hartley O.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17706-11. doi: 10.1073/pnas.0805098105. Epub 2008 Nov 12.


Evolution of CCR5 use before and during coreceptor switching.

Coetzer M, Nedellec R, Salkowitz J, McLaughlin S, Liu Y, Heath L, Mullins JI, Mosier DE.

J Virol. 2008 Dec;82(23):11758-66. doi: 10.1128/JVI.01141-08. Epub 2008 Sep 24.


Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching.

Pastore C, Nedellec R, Ramos A, Hartley O, Miamidian JL, Reeves JD, Mosier DE.

J Virol. 2007 Aug;81(15):8165-79. Epub 2007 May 16.


HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.

Blish CA, Nedellec R, Mandaliya K, Mosier DE, Overbaugh J.

AIDS. 2007 Mar 30;21(6):693-702.


Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding.

Rainwater SM, Wu X, Nduati R, Nedellec R, Mosier D, John-Stewart G, Mbori-Ngacha D, Overbaugh J.

Curr HIV Res. 2007 Mar;5(2):189-97.


Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.

Kiselyeva Y, Nedellec R, Ramos A, Pastore C, Margolis LB, Mosier DE.

J Virol. 2007 Apr;81(7):3657-61. Epub 2007 Jan 3.


Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly.

Wang F, Ruther P, Jiang I, Sawada-Hirai R, Sun SM, Nedellec R, Morrow PR, Kang AS.

Hum Antibodies. 2004;13(4):105-10.


Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.

Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS.

J Immune Based Ther Vaccines. 2004 May 12;2(1):5.

Supplemental Content

Loading ...
Support Center